3M (MMM) PT Lowered to $186 at Jefferies

Jefferies analyst Laurence Alexander lowered the price target on 3M (NYSE: MMM) to $186.00 (from $187.00) while maintaining a Hold rating.

The analyst comments "Excluding $0.04 in deal amortization, Q3 EPS was $0.09 above our estimate ($0.01 above our top-down LEI model) and $0.07 above consensus. 3M raised 2026 EPS guidance to $9.10-$9.15 (vs $8.95-$9.10), after raising it ~3% last quarter. Demand remains mixed, with sales outpacing end-markets. Productivity and price/mix likely supports ~200bps YoY EBIT margin expansion in 2026, and at least 50bps in 2027."

You May Also Be Interested In

• Meta's Muse AI to counter China models with subscribers, not ads, Alexandr Wang says - Nikkei
• Tango Therapeutics Inc. (TNGX) PT Raised to $45 at Wedbush
• Zymeworks (ZYME) PT Raised to $52 at Jefferies